Carl Zeiss Meditec (ETR:AFX) said today it is acquiring cloud-based ophthalmological tech developer Veracity Innovations for an undisclosed amount.
Veracity Innovations developed and produces a cloud-based surgical planning platform for cataract surgeries, covering initial planning, management and analysis of the procedures.
The system is designed to interface directly with multiple electronic medical records and diagnostic devices, covering patients from initial consultation through post-operation, Carl Zeiss said.
“Digital technology is fundamentally changing our world and has a major impact in healthcare. Efficiently bringing together relevant information and making smart use of data in a secure way, along with artificial intelligence, is reshaping how medicine is practiced today, and is opening up new realms of possibility for advancing patient care. Zeiss is constantly addressing future-forward trends, such as digitalization, to give doctors innovative solutions to help patients,” Carl Zeiss prez & CEO Dr. Ludwin Monz said in a prepared statement.
“Zeiss already provides advanced digital solutions that support doctors in their clinical decisions and provide for efficient data management. Our Zeiss Forum system with its clinical workplaces connects the diagnostic devices within a practice, then integrates and delivers this information from multiple modalities at the point of care – in the office and in the OR. Now we are complementing this with the Veracity platform – a simple, cloud-based solution that provides doctors, and their teams, exactly the information they need at each step in the clinical process so they can work more efficiently, mitigate risks, and achieve the very best possible outcomes for their patients. Veracity has a great team and we welcome everyone to Zeiss,” Carl Zeiss ophthalmic devices global prez Jim Mazzo said in a press release.
Veracity launched its platform in May at the American Society of Cataract and Refractive Surgery conference, Carl Zeiss said.
“We are excited to join forces with the Zeiss team that includes leaders in innovation who have collaborated with doctors on developing and bringing to market so many groundbreaking medical technologies. Zeiss has the vision and the expertise to bring this technology to the next level and is set to revolutionize cataract surgery and extend this solution to transform other applications in ophthalmology and beyond,” Veracity Innovations co-founder Dr. Kerry Solomon said in a press release.
Last September, Carl Zeiss said it won FDA premarket approval for its VisuMax femtosecond laser, with indications for small incision lenticule extraction procedures to reduce or eliminate nearsightedness in patients 22 or older.
